SCHEMBL4458073

SCHEMBL4458073

CC(CC(N)=O)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
MAOA P21397 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
EPHX1 P07099 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CYP2A6 P11509 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
CYP1A2 P05177 1/20 0.48
CPA1 P15085 2/20 0.47
CPB1 P15086 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16488807 0.84 CPA1 (0.60) NPC1RAB9ACYP1A2CPA1CPB1
SCHEMBL750878 0.84 CPA1 (0.60) NPC1RAB9ACYP1A2CPA1CPB1
SCHEMBL14542152 0.84 CPA1 (0.60) NPC1RAB9ACYP1A2CPA1CPB1
SCHEMBL21427056 0.83 EPHX1 (0.43) EPHX1
SCHEMBL10835297 0.82 ALPI (0.52) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL9863278 0.82 CPA1 (0.58) NPC1RAB9ACYP1A2CPA1CPB1
SCHEMBL16691549 0.82 ALPI (0.52) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL21149836 0.81 EPHX1 (0.47) SLC6A2TAAR1MAOASLC6A4SLC6A3
SCHEMBL661213 0.81 TSHR (0.51) ANPEP
SCHEMBL1697731 0.81 CYP1A2 (0.44) SLC6A2TAAR1EPHX1PTGS1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017216726-A1 SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-12-21 WO claimed
US-5245004-A ANHYDROUS POLYMERIZATION OF CAPROLACTAM WITH CATALYST, COCATALYST AND ACTIVATOR UNITIKA LTD. (JP) 1993-09-14 US claimed
EP-0522533-A1 Process for polymerizing epsilon-caprolactam UNITIKA LTD. (JP) 1993-01-13 EP claimed
WO-2024012554-A1 TPK AGONIST AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING SAME 上海日馨医药科技股份有限公司 2024-01-18 WO disclosed
EP-3784660-A1 ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS Georgia State University Research Foundation, Inc. (US) 2021-03-03 EP disclosed
EP-2102169-A1 INDAZOLYL ESTER AND AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS AstraZeneca AB (SE) 2009-09-23 EP disclosed
WO-2008076048-A1 INDAZOLYL ESTER AND AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2008-06-26 WO disclosed
WO-2001002364-A1 NEW NPY ANTAGONISTS ASTRAZENECA AB (SE) 2001-01-11 WO disclosed
US-5245004-A ANHYDROUS POLYMERIZATION OF CAPROLACTAM WITH CATALYST, COCATALYST AND ACTIVATOR UNITIKA LTD. (JP) 1993-09-14 US disclosed
EP-0522533-A1 Process for polymerizing epsilon-caprolactam UNITIKA LTD. (JP) 1993-01-13 EP disclosed